rs397516784
Variant summary
The NM_002667.5(PLN):c.40_42delAGA (p.Arg14del) variant causes a conservative inframe deletion change. The variant results in an in-frame change. The variant allele was found at a cumulative frequency of 0.0000062 (AC=10) in the gnomAD database across 1,613,470 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00000488. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.28). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000061240: Multiple functional studies, including mouse models, all support that the Arg14del variant impacts protein function (Haghighi 2006, Ceholski 2012 a, Ceholski 2012b, Haghighi 2012)." and additional evidence is available in ClinVar.
Frequency
Consequence
NM_002667.5 conservative_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathy 1PInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- intrinsic cardiomyopathyInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia
- hypertrophic cardiomyopathy 18Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: MODERATE Submitted by: ClinGen, PanelApp Australia
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- lissencephaly 10Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
- lissencephaly due to LIS1 mutationInheritance: AD Classification: STRONG Submitted by: Illumina
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 13 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000061240: Multiple functional studies, including mouse models, all support that the Arg14del variant impacts protein function (Haghighi 2006, Ceholski 2012 a, Ceholski 2012b, Haghighi 2012).; SCV000236300: An in vitro functional study reported that R14del is a partial inhibitor of the sarcoplasmic reticulum calcium pump, and that it inhibits the phospholamban-protein kinase A interaction (Ceholski et al., 2012).; SCV000280420: Multiple functional studies, including mouse models, all support that the Arg14del variant impacts protein function (Haghighi 2006, Ceholski 2012a, Ceholski 2012b, Haghighi 2012).; SCV003802801: "In-vitro cell culture-based functional studies have shown that this variant results in the inhibition of SERCA, which is an important ATP-dependent calcium pump in the sarcoplasmic reticulum, and in-vivo studies have shown that transgenic mice that express this variant in the heart recapitulate the human cardiac phenotype." PMID:16432188; PMID:22155237; PMID:22427649; SCV000287496: Experimental studies have shown that this variant affects PLN function (PMID: 16432188, 22155237, 22707725).; SCV002557137: Functional analysis has shown that this variant has a dominant negative effect and results in sarcoplasmic reticulum Ca2+-ATPase inhibition. Additionally, transgenic mice develop DCM, abnormal histopathology and suffer premature death (PMID: 16432188).; SCV000318486: Functional assays have demonstrated that this alteration disrupts protein function and leads to dominant negative effects (Haghighi K et al. Proc Natl Acad Sci. U.S.A. 2006;103(5):1388-93; Haghighi K et al. J Mol Cell Cardiol. 2012;52(3):773-82; Ceholski D et al. J Biol Chem. 2012;287(32):26596-605; Ceholski DK et al. J Biol Chem. 2012;287(20):16521-9).; SCV006076320: Multiple functional studies, including mouse models, have demonstrated that the p.Arg14del variant has a deleterious impact on protein function (PMID:22707725; PMID:22155237; PMID:27450564). | ||
| PM1Mutational hot spot or critical domain | UniProt domain with ≥4 pathogenic missense and OR ≥ 5 vs. background — hotspot (PM1); In-domain: 5 pathogenic, 1 benign rare missense variants (OR vs. background: 18.3).; ±8 AA neighbourhood: 4 pathogenic, 0 benign (OR vs. background: 45.0). | ||
| PM2Absent/extremely low in population databases | Very rare in gnomAD for AD/XL gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.00000488 — very rare for AD+AR gene (threshold 0.0001) — PM2 moderate. | ||
| PM4Protein length change in non-repeat region | Single amino-acid in-frame indel in non-repetitive region — protein length change, supporting (PM4 +1); In-frame indel in non-repetitive region — protein length change (1 AA). | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (21/22 total P/LP). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_002667.5. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PLN | MANE Select | c.40_42delAGA | p.Arg14del | conservative_inframe_deletion | Exon 2 of 2 | NP_002658.1 | Q5R352 | ||
| CEP85L | MANE Select | c.1020+6570_1020+6572delCTT | intron | N/A | NP_001035940.1 | Q5SZL2-1 | |||
| CEP85L | c.1029+6570_1029+6572delCTT | intron | N/A | NP_001171506.1 | Q5SZL2-4 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PLN | TSL:1 MANE Select | c.40_42delAGA | p.Arg14del | conservative_inframe_deletion | Exon 2 of 2 | ENSP00000350132.5 | P26678 | ||
| CEP85L | TSL:1 MANE Select | c.1020+6570_1020+6572delCTT | intron | N/A | ENSP00000357477.3 | Q5SZL2-1 | |||
| CEP85L | TSL:1 | c.1029+6570_1029+6572delCTT | intron | N/A | ENSP00000392131.1 | A2A3P3 |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000131 | AC:2 | Hom:0 | AN:152178 | Cov:32 |
GnomAD2 exomes | AF: 0.00000398 | AC:1 | AN:251122 | ||
GnomAD4 exome | AF: 0.00000547 | AC:8 | Hom:0 | AN:1461292 | |
GnomAD4 genome | AF: 0.0000131 | AC:2 | Hom:0 | AN:152178 | Cov:32 |
TOPMed (Bravo) | AF: 0.00000756 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000445 | AC:1 | Hom:0 | AN:22458 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
BipEx | 0.00 | 0 | 28420 | 0.0000347 | 1 | 28844 |
Epi25 | 0.00 | 0 | 41958 | 0.0000150 | 1 | 66888 |
SCHEMA | 0.00 | 0 | 113152 | 0.0000105 | 2 | 190650 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Mutation Taster | N/A | 42/58 | disease causing (ClinVar) |
PhyloP100 | Pathogenic | 8.3 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.